MTOR and neoplasm: After the inclusion of miR-199a-3p, exosomes secreted by ADSCs (ADSC-exo-199a) effectively targeted mammalian target of rapamycin (mTOR), which increased the sensitivity of tumors to chemotherapeutic drugs and significantly reduced the tumor volume (Lou et al., 2020).